Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
January 21, 2014
A new paradigm for transcription factor TFIIB functionality
Vladimir Gelev, Janice M Zabolotny, Martin Lange, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing
Timothy A Lewis, Luc de Waal, Xiaoyun Wu, et al.
Nature Structural & Molecular Biology
|
October 30, 2012
Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity
Cecilia Ballaré, Martin Lange, Audrone Lapinaite, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 24, 2008
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients
Joel D Kopple, Alfred K Cheung, Jens Sandahl Christiansen, et al.
ACS Medicinal Chemistry Letters
|
October 16, 2024
Discovery of BAY 2666605, a Molecular Glue for PDE3A and SLFN12
Timothy A Lewis, Manuel Ellermann, Charlotte Kopitz, et al.
Journal of Biomolecular Screening
|
May 29, 2016
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
Karsten Boehnke, Philip W Iversen, Dirk Schumacher, et al.
Science Advances
|
August 22, 2020
The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation
Pedro Vizán, Arantxa Gutiérrez, Isabel Espejo, et al.
Cell Reports
|
December 7, 2017
Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells
Joseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
Iscience
|
June 18, 2021
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence
Joseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
American Heart Journal
|
September 7, 2016
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1
Steven P Marso, Darren K McGuire, Bernard Zinman, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
January 21, 2014
A new paradigm for transcription factor TFIIB functionality
Vladimir Gelev, Janice M Zabolotny, Martin Lange, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing
Timothy A Lewis, Luc de Waal, Xiaoyun Wu, et al.
Nature Structural & Molecular Biology
|
October 30, 2012
Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity
Cecilia Ballaré, Martin Lange, Audrone Lapinaite, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
October 24, 2008
OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients
Joel D Kopple, Alfred K Cheung, Jens Sandahl Christiansen, et al.
ACS Medicinal Chemistry Letters
|
October 16, 2024
Discovery of BAY 2666605, a Molecular Glue for PDE3A and SLFN12
Timothy A Lewis, Manuel Ellermann, Charlotte Kopitz, et al.
Journal of Biomolecular Screening
|
May 29, 2016
Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures
Karsten Boehnke, Philip W Iversen, Dirk Schumacher, et al.
Science Advances
|
August 22, 2020
The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation
Pedro Vizán, Arantxa Gutiérrez, Isabel Espejo, et al.
Cell Reports
|
December 7, 2017
Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells
Joseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
Iscience
|
June 18, 2021
RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence
Joseph L Regan, Dirk Schumacher, Stephanie Staudte, et al.
American Heart Journal
|
September 7, 2016
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1
Steven P Marso, Darren K McGuire, Bernard Zinman, et al.
Page
of 11